These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 38709662)
1. Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020. Johansson KS; Jimenez-Solem E; Petersen TS; Christensen MB Diabetes Care; 2024 May; ():. PubMed ID: 38709662 [TBL] [Abstract][Full Text] [Related]
2. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication. Loeppenthin K; Dalton SO; Johansen C; Andersen E; Christensen MB; Pappot H; Petersen LN; Thisted LB; Frølich A; Mortensen CE; Lassen U; Ørsted J; Bidstrup PE Br J Cancer; 2020 Sep; 123(6):1033-1040. PubMed ID: 32632149 [TBL] [Abstract][Full Text] [Related]
3. Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018. Thunbo MØ; Vendelbo JH; Witte DR; Larsen A; Pedersen LH Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1210-1223. PubMed ID: 38491733 [TBL] [Abstract][Full Text] [Related]
4. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries. Almodóvar AS; Nahata MC J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057 [TBL] [Abstract][Full Text] [Related]
5. Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy. Fried TR; Mecca MC J Am Geriatr Soc; 2019 Jun; 67(6):1123-1127. PubMed ID: 30697698 [TBL] [Abstract][Full Text] [Related]
6. Appropriateness and surveillance of medication in a cohort of diabetic patients on polypharmacy. Harder S; Saal K; Blauth E; Beyer M; Gerlach FM Int J Clin Pharmacol Ther; 2009 Feb; 47(2):104-10. PubMed ID: 19203566 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Subramanian A; Azcoaga-Lorenzo A; Anand A; Phillips K; Lee SI; Cockburn N; Fagbamigbe AF; Damase-Michel C; Yau C; McCowan C; O'Reilly D; Santorelli G; Hope H; Kennedy JI; Abel KM; Eastwood KA; Locock L; Black M; Loane M; Moss N; Plachcinski R; Thangaratinam S; Brophy S; Agrawal U; Vowles Z; Brocklehurst P; Dolk H; Nelson-Piercy C; Nirantharakumar K; BMC Med; 2023 Jan; 21(1):21. PubMed ID: 36647047 [TBL] [Abstract][Full Text] [Related]
8. Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort. van Oort S; Rutters F; Warlé-van Herwaarden MF; Schram MT; Stehouwer CD; Tack CJ; Abbink EJ; Wolffenbuttel BH; van der Klauw MM; DeVries JH; Siegelaar SE; Sijbrands EJ; Özcan B; de Valk HW; Silvius B; Schroijen MA; Jazet IM; van Ballegooijen AJ; Beulens JWJ; Elders PJ; Kramers C; Diabet Med; 2021 Apr; 38(4):e14406. PubMed ID: 32961611 [TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and chronic pain: harm exposure is not all about the opioids. Giummarra MJ; Gibson SJ; Allen AR; Pichler AS; Arnold CA Pain Med; 2015 Mar; 16(3):472-9. PubMed ID: 25280054 [TBL] [Abstract][Full Text] [Related]
10. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study. Prendergast C; Flood M; Murry LT; Clyne B; Fahey T; Moriarty F BMC Geriatr; 2023 Nov; 23(1):755. PubMed ID: 37978448 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of drug-related problems in older polypharmacy primary care patients. Kovačević SV; Miljković B; Ćulafić M; Kovačević M; Golubović B; Jovanović M; Vučićević K; de Gier JJ J Eval Clin Pract; 2017 Aug; 23(4):860-865. PubMed ID: 28370742 [TBL] [Abstract][Full Text] [Related]
12. Polypharmacy and nutritional status in older adults: a cross-sectional study. Heuberger RA; Caudell K Drugs Aging; 2011 Apr; 28(4):315-23. PubMed ID: 21428466 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy. Rea F; Biffi A; Ronco R; Franchi M; Cammarota S; Citarella A; Conti V; Filippelli A; Sellitto C; Corrao G JAMA Netw Open; 2021 Jun; 4(6):e2113186. PubMed ID: 34125221 [TBL] [Abstract][Full Text] [Related]
14. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Sato I; Akazawa M Drug Healthc Patient Saf; 2013; 5():143-50. PubMed ID: 23843704 [TBL] [Abstract][Full Text] [Related]
15. Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia. Adem L; Tegegne GT Clin Interv Aging; 2022; 17():509-517. PubMed ID: 35464156 [TBL] [Abstract][Full Text] [Related]
16. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy. McIntyre C; McQuillan R; Bell C; Battistella M Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321 [TBL] [Abstract][Full Text] [Related]
17. Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment. Ramsdale E; Mohamed M; Yu V; Otto E; Juba K; Awad H; Moorthi K; Plumb S; Patil A; Vogelzang N; Dib E; Mohile S Oncologist; 2022 Jul; 27(7):e580-e588. PubMed ID: 35348764 [TBL] [Abstract][Full Text] [Related]
18. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study. Runganga M; Peel NM; Hubbard RE Clin Interv Aging; 2014; 9():1453-62. PubMed ID: 25214773 [TBL] [Abstract][Full Text] [Related]
19. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients. Duncan I; Maxwell TL; Huynh N; Todd M Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276 [TBL] [Abstract][Full Text] [Related]